Prevention of postpartum hemorrhage in caesarean section with carbetocin

Authors: V. Korečko;  A. Hudec;  J. Turek
Authors‘ workplace: Gynekologicko-porodnická klinika, FN Plzeň
Published in: Prakt Gyn 2011; 15(3-4): 149-151
Category: Original Article


To determine whether carbetocin administration during a caesarean section can lead to a significant blood loss reduction and a reduced need for subsequent blood transfusion.

Material and methods:
In this retrospective study, we compared caesarean sections performed in two subsequent periods. Group A included all (965) caesarean sections in 2009; oxytocin alone was given to prevent postpartal hemorrhage. Caesarean sections from the second semester 2010 and the first semester 2011 (963 patients) were enrolled in group B. 26.8% of these patients were co-administered Duratocin. Blood transfusion was given for circulatory instability or when hemoglobin declined to less than 78 mg/dl.

The incidence of postpartal hemorrhage and the need for blood transfusion was significantly lower in group B. 112 transfusion units of erythrocyte mass (TU) were given in group A in comparison to 80 TU in group B. The incidence reduction was 31%, reaching statistical significance at the p < 0.05 level.

Carbetocin administration was proven to lead to a significant reduction in the need for post-caesarean section blood transfusion.

Key words:
postpartal hemorrhage – caesarean section – carbetocin – uterine atony – transfusion


1. Smith JR, Ramus RM, Brennan BG et al. Postpartum Hemorrhage Treatment & Management. Available from:

2. Rogers M, Chang A. Postpartum Hemorrhage and Other Problems of the Third Stage. In: James D, Steer P, Weiner C et al (eds). High risk pregnancy. 3rd ed. Philadelphia: Saunders Elsevier 2006: 1559–1578.

3. Magann EF, Evans S, Hutchinson M et al. Postpartum hemorrhage after cesarean delivery: an analysis of risk factors. South Med J 2005; 6(1): 681–685.

4. B-Lynch C, Keith LG, Karoshi M et al. A text-book of postpartum hemorrhage. Dumfries: Sapiens Publishing 2006.

5. Product Information: Duratocin(R), carbetocin. Ferring Pharmaceuticals, Toronto, Canada (PI revised 7/2000) reviewed 7/2000.

Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account